Court ruling likely to boost spirits and ultimately transactions in the sector
Source
Author: unknown
Healthcare M&A: Titans on spree as regulatory crackdown falls flat [Mergers & Acquisitions]
Related Posts
Looming Pharma Tariffs Reshape Biotech Landscape: Supply Chain Upheaval and Dealmaking Pause Send Shockwaves Through Industry
The pharmaceutical and biotechnology sectors face unprecedented disruption as President Trump's proposed 10-25% tariffs on imported drugs and medical devices threaten to upend global supply chains,...
Bain Capital Nears $2.6 Billion HealthEdge Acquisition in Strategic Healthcare Tech Expansion
Private equity heavyweight Bain Capital is finalizing a $2.6 billion acquisition of healthcare technology leader HealthEdge Software from Blackstone Group, according to multiple sources familiar...
Eli Lilly’s Potential Acquisition of Scorpion Therapeutics: A Strategic Shift Amid Market Volatility
Strategic Acquisition: Eli Lilly's potential acquisition of Scorpion Therapeutics signals a strategic move to bolster its oncology pipeline and enhance innovation capabilities. Biotech Market...
Biogen Bids for Sage Therapeutics: Boosting Neuroscience & Psychiatric Treatments
Strategic Rationale: Biogen's bid to acquire Sage Therapeutics' remaining stake aligns with its long-term strategy to expand neuroscience capabilities and strengthen its psychiatric and neurological...